Indication
Vaccination to prevent anal cancer due to human papillomavirus
Anal cancer due to human papillomavirus (HPV) is a malignancy arising from the mucosal or squamous epithelium of the anal canal and perianal region, predominantly manifesting as squamous cell carcinoma. Read more about Vaccination to prevent anal cancer due to human papillomavirus
5 drugs 2 manufacturers
Drugs that treat it
Common Vaccination to prevent anal cancer due to human papillomavirus therapies.
GARDASIL 9 (human papillomavirus vaccine, 9-valent/PF)
GARDASIL 9 (PF) (human papillomavirus vaccine, 9-valent/PF)
GARDASIL 9 (PF) (human papillomavirus vaccine, 9-valent/PF)
GARDASIL 9 (human papillomavirus vaccine, 9-valent/PF)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAnal cancer due to human papillomavirus (HPV) is a malignancy arising from the mucosal or squamous epithelium of the anal canal and perianal region, predominantly manifesting as squamous cell carcinoma.
Pathophysiologically, persistent infection with high-risk oncogenic HPV subtypes—most notably HPV-16 and HPV-18—drives cellular transformation through viral oncoproteins that disrupt host tumor suppressor pathways, progressing through precancerous anal intraepithelial neoplasia (dysplasia).
While relatively rare in the general population, it disproportionately affects immunocompromised individuals, including people living with HIV, solid organ transplant recipients, and men who have sex with men.
Clinically, affected patients may remain asymptomatic or develop local symptoms such as rectal bleeding, anal pain, pruritus, tenesmus, or a palpable anal mass.
- nih.gov
Anal cancer due to human papillomavirus (HPV) is a malignancy arising from the mucosal or squamous epithelium of the anal canal and perianal region, predominantly manifesting as squamous cell carcinoma
- emory.edu
Anal cancer due to human papillomavirus (HPV) is a malignancy arising from the mucosal or squamous epithelium of the anal canal and perianal region, predominantly manifesting as squamous cell carcinoma
- theoncologynurse.com
Pathophysiologically, persistent infection with high-risk oncogenic HPV subtypes—most notably HPV-16 and HPV-18—drives cellular transformation through viral oncoproteins that disrupt host tumor suppressor pathways, progressing through precancerous anal intraepithelial neoplasia (dysplasia)
- analcancerfoundation.org
Pathophysiologically, persistent infection with high-risk oncogenic HPV subtypes—most notably HPV-16 and HPV-18—drives cellular transformation through viral oncoproteins that disrupt host tumor suppressor pathways, progressing through precancerous anal intraepithelial neoplasia (dysplasia)
- hopkinsmedicine.org
Pathophysiologically, persistent infection with high-risk oncogenic HPV subtypes—most notably HPV-16 and HPV-18—drives cellular transformation through viral oncoproteins that disrupt host tumor suppressor pathways, progressing through precancerous anal intraepithelial neoplasia (dysplasia) While relatively rare in the general population, it disproportionately affects immunocompromised individuals, including people living with HIV, solid organ transplant recipients, and men who have sex with men ...
- asccp.org
While relatively rare in the general population, it disproportionately affects immunocompromised individuals, including people living with HIV, solid organ transplant recipients, and men who have sex with men
- hpvworld.com
While relatively rare in the general population, it disproportionately affects immunocompromised individuals, including people living with HIV, solid organ transplant recipients, and men who have sex with men
- osu.edu
Clinically, affected patients may remain asymptomatic or develop local symptoms such as rectal bleeding, anal pain, pruritus, tenesmus, or a palpable anal mass
Personalize your experience
Follow Vaccination to prevent anal cancer due to human papillomavirus and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.